MAR 12, 2015 12:00 PM PDT

Dynamics of Narcolepsy

WRITTEN BY: Ilene Schneider
Narcolepsy, a chronic central nervous system disorder that occurs when the brain cannot normally regulate cycles of sleep and being awake, causes episodes of sleepiness and sleep unpredictably during the day. One in 3,000 Americans suffers from it. Onset is between ages 10 and 25, and the disease is then permanent. Besides the disruption to normal life caused by sudden sleep, there is loss of muscle tone, slurred speech, difficulty in concentrating, and even hallucinations. Narcolepsy's mechanism has been unknown, and there is currently no treatment or cure.

"Narcolepsy is interesting, because although it has been considered to be strictly genetic, it is induced by environmental factors, such as a burst of laughter, or stress, said researcher Dr. Yehuda Shoenfeld of Tel Aviv University. "Narcolepsy is devastating to those suffering from it and debilitating to children in particular. There is no known therapy to treat it."

Dr. Shoenfeld and his team got interested in narcolepsy when there was an upsurge of narcolepsy diagnoses in Finland in 2009 after there was a public campaign to distribute the H1N1 flu vaccine. After the campaign, the occurrence of narcolepsy went up to 16 times the average. Now a study in the journal Pharmacological Research by Dr. Shoenfeld, his student Maria-Teresa Arango, and collaborator Dr. Makato Honda of the Tokyo Metropolitan Institute of Psychiatry, suggests that an autoimmune disorder, attacking a particular type of neuron in the brain, may be the cause of narcolepsy.

Orexin neurons are known to regulate sleep and wakefulness; granules called tribbles are sites of orexin concentration in the brain. Research suggested that an apparent autoantibody attacks tribbles. According to Dr. Shoenfeld, "In patients and animals that develop narcolepsy, we have seen an evident depletion of orexin in the brain and therefore a lack of balance, and later attacks of narcolepsy. Why is the orexin disappearing? We think the culprit is an autoimmune reaction -- the binding of autoantibodies to the tribble granules to destroy them."

Suspected antibodies were isolated, injected into mice, and then sleep patterns observed. "What we saw was an increased number of sleep attacks and irregular patterns of sleep. Mice fall asleep like dogs, circling around before going to sleep. Suddenly, in this experiment, the mice just dropped off to sleep and then, just two minutes later, woke up as though nothing had happened," Dr. Shoenfeld said.

"Our hope is to change the perception and diagnosis of narcolepsy, to define it as the 81st known autoimmune disease, because a better understanding of the mechanism will lead to better treatment, and maybe one day a cure, " Dr. Shoenfeld concluded.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
DEC 30, 2020
Neuroscience
Do Psychedelics Reduce Trauma from Racial Injustice?
DEC 30, 2020
Do Psychedelics Reduce Trauma from Racial Injustice?
Researchers from Ohio State University have found that a single positive experience on psychedelics may reduce stress, d ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
JAN 09, 2021
Cannabis Sciences
Over 50% on Medical Cannabis Experience Withdrawal Symptoms
JAN 09, 2021
Over 50% on Medical Cannabis Experience Withdrawal Symptoms
A new study has found that over half of people who use medical cannabis products for pain relief experience multiple wit ...
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
APR 04, 2021
Genetics & Genomics
Gene Therapy Improves Transport in Neurons
APR 04, 2021
Gene Therapy Improves Transport in Neurons
While this approach was tested on models of eye disorders, prelimary work suggested it also has potential as a dementia ...
APR 10, 2021
Drug Discovery & Development
How New ADHD Drug for Children Differs from Adderall
APR 10, 2021
How New ADHD Drug for Children Differs from Adderall
Over 1 in 10 children in the US aged between 5 and 17 have been diagnosed with attention deficit hyperactivity ...
Loading Comments...